Synapse - Elizabeth Comen

Search Within

Elizabeth Comen

Results (72)

Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Journal Article

Recht, A.; Comen, E. A.; Fine, R. E.; Fleming, G. F.; Hardenbergh, P. H.; Ho, A. Y.; Hudis, C. A.; Hwang, E. S.; Kirshner, J. J.; Morrow, M.; more...
Practical Radiation Oncology (2016)

Fulltext@MSK | Save

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study

Journal Article

Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
Breast Cancer Research and Treatment (2016)

Fulltext@MSK | Save

A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer

Journal Article

Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
Clinical Breast Cancer (2016)

Fulltext@MSK | Save

Somatic mutations in leukocytes infiltrating primary breast cancers

Journal Article

Kleppe, M.; Comen, E.; Wen, H. Y.; Bastian, L.; Blum, B.; Rapaport, F. T.; Keller, M.; Granot, Z.; Socci, N.; Viale, A.; more...
npj Breast Cancer (2015)

Fulltext@MSK | Save

Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result

Meeting Abstract

Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Identifying somatic oncogenic mutations in leukocytes that infiltrate primary breast cancers

Meeting Abstract

Comen, E. A.; Kleppe, M.; Wen, Y. H.; Rapaport, F.; Granot, Z.; Socci, N. D.; Viale, A.; You, D.; Benezra, R.; Weigelt, B.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)

Meeting Abstract

Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Somatic leukemogenic mutations associated with infiltrating white blood cells in breast cancer patients

Meeting Abstract

Comen, E. A.; Kleppe, M.; Wen, H.; Weigelt, B.; Bastian, L.; Blum, B.; Rapaport, F. T.; Keller, M.; Socci, N.; Viale, A.; more...
Cancer Research (2015)

Fulltext@MSK | Save